Login / Signup

Inhibition of the PI3K/mTOR Pathway in Breast Cancer to Enhance Response to Immune Checkpoint Inhibitors in Breast Cancer.

Chi YanJinming YangNabil SalehSheau-Chiann ChenGregory D AyersVandana G AbramsonIngrid A MayerAnn Richmond
Published in: International journal of molecular sciences (2021)
PI3K/mTOR inhibition plus PTX heightens response to ICI and may provide a viable therapeutic approach for treatment of metastatic BC.
Keyphrases
  • cell proliferation
  • squamous cell carcinoma
  • small cell lung cancer
  • combination therapy
  • replacement therapy
  • smoking cessation